Assessment of bone synthetic activity in inflammatory lesions and syndesmophytes in patients with ankylosing spondylitis: The potential role of 18F-fluoride positron emission tomography-magnetic resonance imaging

Clinical and Experimental Rheumatology

Volumn 33, Issue 1, 2015, Pages 90-97

  Lee, Seung Geun ^a   Kim, In Joo ^a   Kim, Keun Young ^b   Kim, Hee Young ^a   Pak, Kyoung June ^a   Kim, Seong Jang ^a   Park, Eun Kyoung ^a   Jeon, Yun Kyung ^a   Yang, Byeong Yun ^a   Kim, Geun Tae ^b  

^a Pusan National University School of Medicine   (South Korea)

^b Kosin University College of Medicine   (South Korea)

Author keywords

Ankylosing spondylitis; Fluoride; Osteoblast; Positron emission tomography

Indexed keywords

FLUORINE 18; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

ACUTE CORNER INFLAMMATORY LESION; ADULT; ADVANCED CORNER INFLAMMATORY LESION; ANKYLOSING SPONDYLITIS; ARTICLE; BONE DEMINERALIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; HUMAN; IMAGE QUALITY; INFLAMMATION; ISOTOPE TRACING; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; OSSIFICATION; PET-MRI SCANNER; POSITRON CAMERA; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SPINE DISEASE; SPINE RADIOGRAPHY; SYNDESMOPHYTE; VERTEBRA BODY; BONE DEVELOPMENT; CASE CONTROL STUDY; DIAGNOSTIC USE; MIDDLE AGED; MULTIMODAL IMAGING; OSTEOBLAST; PATHOLOGY; PREDICTIVE VALUE; SCINTISCANNING; SPINE; SPONDYLITIS, ANKYLOSING; STATISTICAL MODEL;

ADULT; CASE-CONTROL STUDIES; FLUORODEOXYGLUCOSE F18; HUMANS; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIMODAL IMAGING; OSTEOBLASTS; OSTEOGENESIS; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SPINE; SPONDYLITIS, ANKYLOSING;

EID: 84928704141     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. van der HEIJDE D, LANDEWé R, EINSTEIN S et al.: Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept. Arthritis Rheum 2008; 58: 1324-31.
2. van der HEIJDE D, LANDEWé R, BARALIAKOS X et al.: Radiographic findings following two years of infliximab therapy in patients with ankylosing spondylitis. Arthritis Rheum 2008; 58: 3063-70.
3. van der HEIJDE D, SALONEN D, WEISSMAN BN et al.: Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years. Arthritis Res Ther 2009; 11: R127.
4. BARALIAKOS X, LISTING J, RUDWALEIT M, SIEPER J, BRAUN J: The relationship between inflammation and new bone formation in patients with ankylosing spondylitis. Arthritis Res Ther 2008; 10: R104.
5. MAKSYMOWYCH WP, CHIOWCHANWISAWAKIT P, CLARE T, PEDERSEN SJ, OSTERGAARD M, LAMBERT RG: Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis: evidence of a relationship between inflammation and new bone formation. Arthritis Rheum 2009; 60: 93-102.
6. van der HEIJDE D, MACHADO P, BRAUN J et al.: MRI inflammation at the vertebral unit only marginally predicts new syndesmophyte formation: a multilevel analysis in patients with ankylosing spondylitis. Ann Rheum Dis 2012; 71: 369-73.
7. SIEPER J, APPEL H, BRAUN J, RUDWALEIT M: Critical appraisal of assessment of structural damage in ankylosing spondylitis: implications for treatment outcomes. Arthritis Rheum 2008; 58: 649-56.
8. LORIES RJ, SCHETT G: Pathophysiology of new bone formation and ankylosis in spondyloarthritis. Rheum Dis Clin North Am 2012; 38: 555-67.
9. MAKSYMOWYCH WP: Disease modification in ankylosing spondylitis. Nat Rev Rheumatol 2010; 6: 75-81.
10. BRAUN J, BARALIAKOS X: Imaging of axial spondyloarthritis including ankylosing spondylitis. Ann Rheum Dis 2011; 70 (Suppl. 1): i97-103.
11. CARMONA L, SELLAS A, RODRIGUEZ-LOZANO C et al.: Scoring with the Berlin MRI method for assessment of spinal inflammatory activity in patients with ankylosing spondylitis: a calibration exercise among rheumatologists. Clin Exp Rheumatol 2013; 31: 883-8.
12. APPEL H, LODDENKEMPER C, GROZDA-NOVIC Z et al.: Correlation of histopathological findings and magnetic resonance imaging in the spine of patients with ankylosing spondylitis. Arthritis Res Ther 2006; 8: R143.
13. SIEPER J, RUDWALEIT M, BARALIAKOS X et al.: The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis 2009; 68 (Suppl. 2): ii1-44.
14. LI Y, SCHIEPERS C, LAKE R, DADPARVAR S, BERENJI GR: Clinical utility of (18)F-fluoride PET/CT in benign and malignant bone diseases. Bone 2012; 50: 128-39.
15. HSU WK, VIRK MS, FEELEY BT, STOUT DB, CHATZIIOANNOU AF, LIEBERMAN JR: Characterization of osteolytic, osteoblastic, and mixed lesions in a prostate cancer mouse model using 18F-FDG and 18F-fluoride PET/CT. J Nucl Med 2008; 49: 414-21.
16. BRUIJNEN ST, van der WEIJDEN MA, KLEIN JP et al.: Bone formation rather than inflammation reflects ankylosing spondylitis activity on PET-CT: a pilot study. Arthritis Res Ther 2012; 14: R71.
17. TAN AL, TANNER SF, WALLER ML et al.: High-resolution [18F]fluoride positron emission tomography of the distal interphalangeal joint in psoriatic arthritis-a bone-enthesis-nail complex. Rheumatology (Oxford) 2013; 52: 898-904.
18. VAN DER LINDEN S, VALKENBURG HA, CATS A: Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984; 27: 361-8.
19. LAMBERT RGW, PEDERSEN SJ, MAKSY MOWYCH WP, CHIOWCHANWISAWAKIT P, OSTERGAARD M: Active inflammatory lesions detected by magnetic resonance imaging in the spine of patients with spondyloarthritis-definitions, assessment system, and reference image set. J Rheumatol Supplement 2009; 84: 3-17.
20. MAKSYMOWYCH WP, MORENCY N, CONNER-SPADY B, LAMBERT RG: Suppression of inflammation and effects on new bone formation in ankylosing spondylitis: evidence for a window of opportunity in disease modification. Ann Rheum Dis 2013; 72: 23-8.
21. WANDERS AJ, LANDEWé RB, SPOORENBERG A et al.: What is the most appropriate radiologic scoring method for ankylosing spondylitis?. A comparison of the available methods based on the Outcome Measures in Rheumatology Clinical Trials filter. Arthritis Rheum 2004; 50: 2622-32.
22. CHIOWCHANWISAWAKIT P, LAMBERT RG, CONNER-SPADY B, MAKSYMOWYCH WP: Focal fat lesions at vertebral corners on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis. Arthritis Rheum 2011; 63: 2215-25.
23. BARALIAKOS X, HELDMANN F, CALLHOFF J et al.: Which spinal lesions are associated with new bone formation in patients with ankylosing spondylitis treated with anti-TNF agents?. A long-term observational study using MRI and conventional radiography. Ann Rheum Dis. 2013.
24. LORIES RJ, LUYTEN FP, de VLAM K: Progress in spondylarthritis. Mechanisms of new bone formation in spondyloarthritis. Arthritis Res Ther 2009; 11: 221.
25. MESSA C, GOODMAN WG, HOH CK et al.: Bone metabolic activity measured with positron emission tomography and [18F]fluoride ion in renal osteodystrophy: correlation with bone histomorphometry. J Clin Endocrinol Metab 1993; 77: 949-55.
26. PIERT M, ZITTEL TT, BECKER GA et al.: Assessment of porcine bone metabolism by dynamic. J Nucl Med 2001; 42: 1091-100.
27. STROBEL K, FISCHER DR, TAMBORRINI G et al.: 18F-fluoride PET/CT for detection of sacroiliitis in ankylosing spondylitis. Eur J Nucl Med Mol Imaging 2010; 37: 1760-5.
28. FISCHER DR, PFIRRMANN CW, ZUBLER V et al.: High bone turnover assessed by 18F-fluoride PET/CT in the spine and sacroiliac joints of patients with ankylosing spondylitis: comparison with inflammatory lesions detected by whole body MRI. EJNMMI Res 2012; 2: 38.
29. OVADIA D, METSER U, LIEVSHITZ G, YANIV M, WIENTROUB S, EVEN-SAPIR E: Back pain in adolescents: assessment with integrated 18F-fluoride positron-emission tomography-computed tomography. J Pediatr Orthop 2007; 27: 90-3.
30. LIM R, FAHEY FH, DRUBACH LA, CONNOLLY LP, TREVES ST: Early experience with fluorine-18 sodium fluoride bone PET in young patients with back pain. J Pediatr Orthop 2007; 27: 277-82.
31. KIM JH, LEE JS, SONG IC, LEE DS: Comparison of segmentation-based attenuation correction methods for PET/MRI: evaluation of bone and liver standardized uptake value with oncologic PET/CT data. J Nucl Med 2012; 53: 1878-82.
32. SCHULZ V, TORRES-ESPALLARDO I, RENISCH S et al.: Automatic, three-segment, MR-based attenuation correction for whole-body PET/MR data. Eur J Nucl Med Mol Imaging 2011; 38: 138-52.
33. WANDERS A, HEIJDE D, LANDEWé R et al.: Non-steroidal anti-inflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum 2005; 52: 1756-65.
34. KROON F, LANDEWé R, DOUGADOS M, van der HEIJDE D: Continuous NSAID use reverts the effects of inflammation on radiographic progression in patients with ankylosing spondylitis. Ann Rheum Dis 2012; 71: 1623-9.
35. DORAN MF, BROPHY S, MacKAY K, TAYLOR G, CALIN A: Predictors of longterm outcome in ankylosing spondylitis. J Rheumatol 2003; 30: 316-20.